Tumor size assessment for prediction of osimertinib efficacy in EGFR -mutated non–small cell lung cancer
JAAD International
· Elsevier
Аннотация
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tomonobu Nagase, Eiji Iwama, Hiroaki Ogata, Yuki Ikematsu, Daisuke Shibahara, Kohei Otsubo, Yoshimasa Shiraishi, Taishi Harada, Isamu Okamoto
Читать у издателя →
Цитирование
Tumor size assessment for prediction of osimertinib efficacy in EGFR -mutated non–small cell lung cancer. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000525?dgcid=rss_sd_all
Tumor size assessment for prediction of osimertinib efficacy in EGFR -mutated non–small cell lung cancer. JAAD International. https://www.sciencedirect.com/science/article/pii/S3117504X26000525?dgcid=rss_sd_all
“Tumor size assessment for prediction of osimertinib efficacy in EGFR -mutated non–small cell lung cancer.” JAAD International.
@article{article5816,
title = {Tumor size assessment for prediction of osimertinib efficacy in EGFR -mutated non–small cell lung cancer},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000525?dgcid=rss_sd_all}
}